Suchergebnisse - "Riccardi, Federica"

PubPharm (23)

1

Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX-Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B : A Single-Center Retrospective-Prospective Study

enthalten in: Journal of clinical medicine | 2024

von Coppola, A. | Rivolta, G. | Quintavalle, G. | +7

2

The effect of carriers' reproductive choices and pregnancy history on sporadic severe haemophilia : A 20-year retrospective study through a regional registry

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2022

von Riccardi, F. | Coppola, A. | Rivolta, G. | +7

3

The effect of carriers’ reproductive choices and pregnancy history on sporadic severe haemophilia : A 20‐year retrospective study through a regional registry

enthalten in: Haemophilia | 2022

von Riccardi, F. | Coppola, A. | Rivolta, G. | +7

4

Survival analysis for patients with cancer in Gaza applying for Israeli permits to exit the Gaza Strip for health care : a retrospective cohort study of patients from 2008 to 2017

enthalten in: Lancet (London, England) | 2021

von Bouquet, B. | Barone-Adesi, F. | Lafi, M. | +9

5

Comparative survival of cancer patients requiring Israeli permits to exit the Gaza Strip for health care : A retrospective cohort study from 2008 to 2017

enthalten in: PloS one | 2021

von Bouquet, B. | Barone-Adesi, F. | Lafi, M. | +9

6

ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients : A Study from the Italian Association of Hemophilia Centers

enthalten in: Seminars in thrombosis and hemostasis | 2021

von Franchini, M. | Coppola, A. | Santoro, C. | +15

7

Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc : a single-centre real-world experience

enthalten in: Blood transfusion = Trasfusione del sangue | 2020

von Tagliaferri, A. | Matichecchia, A. | Rivolta, G. | +5

8

Therapeutic choices in persons with haemophilia at the time of COVID-19

enthalten in: Blood transfusion = Trasfusione del sangue | 2020

von Coppola, A. | Riccardi, F. | Tagliaferri, A.

9

Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion

enthalten in: Targeted oncology | 2019

von La Monica, S. | Minari, R. | Cretella, D. | +9

10

Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion

enthalten in: Targeted oncology | 2019

von La Monica, S. | Minari, R. | Cretella, D. | +9